Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells
Peroxisome proliferator-activated receptor-γ antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines
Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells
Necrotic pathway in human osteosarcoma Saos-2 cell death induced by chloroacetaldehyde
Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by pterocarnin A from the bark of Pterocarya stenoptera via the Fas-mediated pathway
ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer
Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model
Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer
A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors
Chemoimmunotherapy in the treatment of metastatic gastric cancer
Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer
Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer
Erratum